Technical impact
Farmasimplex downloads a CIP News file via HTTP and executes any SQL statements contained within it against the internal FarmaCIP database with administrative privileges. The flaw allows an attacker who can intercept or replace the HTTP content, or who has compromised vendor infrastructure, to inject arbitrary SQL commands. Successful exploitation can lead to unauthorized database access, modification or deletion, and, as the description states, can even result in operating system command execution. The weakness corresponds to improper handling of external input leading to executable code (CWE‑494).
Affected Systems
The affected product is Farmasimplex from CIPCarbone. No specific version information is listed in the CNA data, so all current installations of Farmasimplex are potentially vulnerable unless mitigated by the vendor.
Risk and Exploitability
The CVSS score of 8.1 places this vulnerability in the high severity range. The EPSS score is not provided, so the current likelihood of exploitation is unknown. The vulnerability is not listed in the CISA KEV catalog. An attacker would need to tamper with the HTTP transport or compromise the vendor’s infrastructure to inject malicious SQL. If the attacker succeeds, the attack can extend beyond the database to execute arbitrary OS commands, representing a severe escalation of privilege. The absence of a publicly available patch or workaround increases the risk profile for affected deployments.